Mandate

Vinge advises Stendörren in connection with issuance of green notes and tender offer

September 13, 2024

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of senior unsecured green notes in an amount of SEK 800 million (within a framework of SEK 1200 million) and its parallel tender offer in respect of its previously issued notes due 2025.

An amount corresponding to the net proceeds from the new notes will be used in accordance with Stendörren’s previously established green financing framework and to repurchase parts of Stendörren’s outstanding senior unsecured notes due 2025.

The notes are intended to be listed on the sustainable bond list of Nasdaq Stockholm. The notes have a tenor of 3.25 years and were issued with a coupon of STIBOR 3m + 290 basis points.

Nordea Bank Abp, Skandinaviska Enskilda Banken AB (publ) and Swedbank AB (publ) acted as joint bookrunners and dealer managers in the transaction.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda, August Ahlin and Rebecka Margolin.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026